FDA Inspection 1321526 — Kentucky Blood Center, Inc.

Kentucky Blood Center, Inc. — FEI 3011192341

The FDA completed an inspection of Kentucky Blood Center, Inc. on June 9, 2026 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 9, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Louisville, KY (United States)